Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHSE: 603207)
Health Care · Pharmaceuticals · CN
CN¥24.00
+1.44% today · -34.8% 1Y
Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHSE: 603207) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $571.74M.
Over the last twelve months the share price has lost 34.8%, trading between 21.31 and 37.65.
Tweenvest scores Shanghai Xiao Fang Pharmaceutical Co.,Ltd. across four factors: value 81/100, growth 38/100, dividend 90/100. Its strongest factor is dividend.
603207 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $571.74M
- Revenue (TTM)
- $78.57M
- P/E
- 18.90
- EPS
- 1.27
- Dividend yield
- 4.46%
- Beta (5Y)
- 0.01
- 52-week high
- CN¥37.65
- 52-week low
- CN¥21.31
- Avg volume (3M)
- —
- Shares outstanding
- 160.67M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,249.40 | +0.20% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.32 | +0.10% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.33 | +3.76% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.44 | +1.66% |
Figures last refreshed Aug 18, 2026.